Is Precision Medicine in Oncology Narrowing Patient Population Too Much?

Kineticos’ Operating Executive Steve Buckanavage continues his discussion with Christopher Heery, M.D., CMO at Precision Biosciences, as they tackle the difficulties that Precision Medicine can bring to Oncology studies. To read the whole article, click the link below. (2019)